- Research works
- 22 ▼ 24% vs 2013–17
- Citations
- 2.1k 93.5 per fractional work
- Top-10% rate
- 24.0% record average 16.5%
- Open access
- 54% world 28%
Not ranked overall: Japan Breast Cancer Research Group is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Japan Breast Cancer Research Group?
By fractional works in all years, weighted toward what it does more of than the world: Hepatocellular Carcinoma, Survival, Treatment, Clinical Practice Guidelines, Liver Cancer, Management, Chemotherapy and Prognostic Factors.
- Prognosis
- NAFLD
- Hepatitis B Virus
- Chronic Hepatitis B
- Global Burden
- Metastasis
- Tumor Microenvironment
- Immune Response
- Targeted Therapy
- Clinical Trials
- Cholangiocarcinoma
- Surgical Management
- Prognostic Factors
- Management
- Treatment
- Survival
- Hepatocellular Carcinoma
- Clinical Practice Guidelines
- Liver Cancer
- Chemotherapy
- Epidemiology
- Biliary Tract Cancer
- Radiotherapy
- Immunotherapy
- Antiviral Therapy
- Liver Disease
- Adjuvant Therapy
- CT Screening
- Lung Cancer
- HIF-1
- Warburg Effect
- NASH
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 32 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 32 words, with their numbers
- Hepatocellular Carcinoma6▲ 131×3 topics
- Survival5▲ 160×2 topics
- Clinical Practice Guidelines4▲ 34×3 topics
- Treatment4▲ 15×2 topics
- Liver Cancer4▲ 349×1 topic
- Management4▲ 23×1 topic
- Chemotherapy4▲ 23×7 topics
- Prognostic Factors3▲ 30×2 topics
- Epidemiology3▲ 3.0×2 topics
- Surgical Management2▲ 25×2 topics
- Biliary Tract Cancer2▲ 299×1 topic
- Cholangiocarcinoma2▲ 133×1 topic
- Radiotherapy2▲ 25×3 topics
- Clinical Trials2▲ 12×2 topics
- Immunotherapy2▲ 12×4 topics
- Targeted Therapy2▲ 35×2 topics
- Antiviral Therapy2▲ 45×2 topics
- Immune Response2▲ 11×2 topics
- Liver Disease2▲ 50×3 topics
- Tumor Microenvironment2▲ 19×2 topics
- Adjuvant Therapy1▲ 57×2 topics
- Metastasis1▲ 18×3 topics
- CT Screening1▲ 104×1 topic
- Global Burden1▲ 11×2 topics
- Lung Cancer1▲ 35×1 topic
- Chronic Hepatitis B1▲ 101×1 topic
- HIF-11▲ 74×1 topic
- Hepatitis B Virus1▲ 101×1 topic
- Warburg Effect1▲ 74×1 topic
- NAFLD1▲ 45×1 topic
- NASH1▲ 45×1 topic
- Prognosis1▲ 16×2 topics
Which research topics does Japan Breast Cancer Research Group publish most on?
By volume in 2022–2025: Hepatocellular Carcinoma Treatment and Prognosis, BRCA gene mutations in cancer, PARP inhibition in cancer therapy and Advanced Breast Cancer Therapies.
- 1 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 0 works
- 2 BRCA gene mutations in cancer Genetics 0 works
- 3 PARP inhibition in cancer therapy Oncology 0 works
- 4 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
- 5 Pancreatic and Hepatic Oncology Research Oncology 0 works
- 6 Medical Case Reports and Studies Surgery 0 works
- 7 Cancer and biochemical research Molecular Biology 0 works
- 8 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Japan Breast Cancer Research Group's research output changed?
Output in 2018–2022 was 24% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tokyo
- The University of Tokyo
- Tokyo Institute of Technology
- Keio University
- Waseda University
- Tokyo University of Science
- Nihon University
- Hitachi (Japan)
- NTT (Japan)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.